Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small-cell lung cancer
Charles M. Rudin, Élisabeth Brambilla, C. Faivre‐Finn, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 992

Showing 1-25 of 992 citing articles:

The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015
Andrew G. Nicholson, Ming‐Sound Tsao, Mary Beth Beasley, et al.
Journal of Thoracic Oncology (2021) Vol. 17, Iss. 3, pp. 362-387
Open Access | Times Cited: 890
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Apar Kishor Ganti, Billy W. Loo, M. Bassetti, et al.
Journal of the National Comprehensive Cancer Network (2021) Vol. 19, Iss. 12, pp. 1441-1464
Open Access | Times Cited: 297
Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer
Joseph M. Chan, Àlvaro Quintanal-Villalonga, Vianne R. Gao, et al.
Cancer Cell (2021) Vol. 39, Iss. 11, pp. 1479-1496.e18
Open Access | Times Cited: 276
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer
Ying Cheng, Liang Han, Lin Wu, et al.
JAMA (2022) Vol. 328, Iss. 12, pp. 1223-1223
Open Access | Times Cited: 263
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions
Zsolt Megyesfalvi, Carl M. Gay, Helmut Popper, et al.
CA A Cancer Journal for Clinicians (2023) Vol. 73, Iss. 6, pp. 620-652
Open Access | Times Cited: 162
Lung neuroendocrine neoplasms: recent progress and persistent challenges
Natasha Rekhtman
Modern Pathology (2021) Vol. 35, pp. 36-50
Open Access | Times Cited: 137
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
Qing Wu, Wei Qian, Xiaoli Sun, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 135
SCLC: Epidemiology, Risk Factors, Genetic Susceptibility, Molecular Pathology, Screening, and Early Detection
Qian Wang, Zeynep H. Gümüş, Cristina Colarossi, et al.
Journal of Thoracic Oncology (2022) Vol. 18, Iss. 1, pp. 31-46
Open Access | Times Cited: 109
Small molecule inhibitors targeting the cancers
Guihong Liu, Tao Chen, Xin Zhang, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 87
Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect
Yoko Nishiga, Alexandros P. Drainas, Maya Baron, et al.
Nature Cancer (2022) Vol. 3, Iss. 11, pp. 1351-1366
Open Access | Times Cited: 85
cfDNA methylome profiling for detection and subtyping of small cell lung cancers
Francesca Chemi, Simon P. Pearce, Alexandra Clipson, et al.
Nature Cancer (2022) Vol. 3, Iss. 10, pp. 1260-1270
Open Access | Times Cited: 82
Traditional Chinese Medicine has great potential as candidate drugs for lung cancer: A review
Zhicheng Wei, Jing Chen, Fang Zuo, et al.
Journal of Ethnopharmacology (2022) Vol. 300, pp. 115748-115748
Closed Access | Times Cited: 79
Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer
Charles M. Rudin, Martin Reck, Melissa L. Johnson, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 78
KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming
Feifei Na, Xiangyu Pan, Jingyao Chen, et al.
Nature Cancer (2022) Vol. 3, Iss. 6, pp. 753-767
Open Access | Times Cited: 76
IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models
Janneke E. Jaspers, Jonathan F. Khan, William D. Godfrey, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 9
Open Access | Times Cited: 75
Signal pathways and precision therapy of small-cell lung cancer
Min Yuan, Yu Zhao, Hendrik‐Tobias Arkenau, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 73
Small cell lung cancer transformation: From pathogenesis to treatment
Xiaomeng Yin, Yueyi Li, Hang Wang, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 595-606
Closed Access | Times Cited: 72
Radiomics and artificial intelligence for precision medicine in lung cancer treatment
Mitchell Chen, Susan J. Copley, Patrizia Viola, et al.
Seminars in Cancer Biology (2023) Vol. 93, pp. 97-113
Open Access | Times Cited: 71
Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation
Smruthy Sivakumar, Jay A. Moore, Meagan Montesion, et al.
Cancer Discovery (2023) Vol. 13, Iss. 7, pp. 1572-1591
Open Access | Times Cited: 70
Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies
Qian Liu, Jing Zhang, Chenchen Guo, et al.
Cell (2024) Vol. 187, Iss. 1, pp. 184-203.e28
Open Access | Times Cited: 66
Drug-tolerant persister cells in cancer: the cutting edges and future directions
Yi Pu, Lu Li, Haoning Peng, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 799-813
Closed Access | Times Cited: 61
Efficient radioactive gas detection by scintillating porous metal–organic frameworks
Matteo Orfano, Jacopo Perego, Francesca Cova, et al.
Nature Photonics (2023) Vol. 17, Iss. 8, pp. 672-678
Open Access | Times Cited: 51
Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen Presentation
Charles M. Rudin, David Balli, W. Victoria Lai, et al.
Journal of Thoracic Oncology (2023) Vol. 18, Iss. 9, pp. 1222-1232
Open Access | Times Cited: 49
MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4/FOXM1/RRM2 axis
Parvez Κhan, Jawed A. Siddiqui, Prakash Kshirsagar, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 43
Evolutionary trajectories of small cell lung cancer under therapy
Julie George, Lukas Maas, Nima Abedpour, et al.
Nature (2024) Vol. 627, Iss. 8005, pp. 880-889
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top